Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 898

1.

Net Clinical Benefit of Dabigatran Over Warfarin in Patients With Atrial Fibrillation Stratified by CHA<sub>2</sub>DS<sub>2</sub>-VASc and Time in Therapeutic Range.

Chan PH, Huang D, Lau CP, Chan EW, Wong IC, Lip GY, Tse HF, Siu CW.

Can J Cardiol. 2016 Jan 25. pii: S0828-282X(16)00056-8. doi: 10.1016/j.cjca.2016.01.016. [Epub ahead of print]

PMID:
27118057
2.

Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.

Nakamura A, Kuroda J, Ago T, Hata J, Matsuo R, Arakawa S, Kuwashiro T, Yasaka M, Okada Y, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators.

Cerebrovasc Dis. 2016 Apr 26;42(3-4):196-204. [Epub ahead of print]

PMID:
27111222
3.

The Prognostic Significance of Cardiac Structure and Function in Atrial Fibrillation: The ENGAGE AF-TIMI 48 Echocardiographic Substudy.

Gupta DK, Giugliano RP, Ruff CT, Claggett B, Murphy S, Antman E, Mercuri MF, Braunwald E, Solomon SD; Effective Anticoagulation with Factor Xa Next Generation in AF–Thrombolysis in Myocardial Infarction 48 (ENGAGE AF–IMI 48) Echocardiographic Study Investigators.

J Am Soc Echocardiogr. 2016 Apr 20. pii: S0894-7317(16)00171-1. doi: 10.1016/j.echo.2016.03.004. [Epub ahead of print]

PMID:
27106009
4.

Efficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-Analysis.

Vallakati A, Sharma A, Madmani M, Reddy M, Kanmanthareddy A, Gunda S, Lakkireddy D, Lewis WR.

Cardiol Ther. 2016 Apr 22. [Epub ahead of print]

PMID:
27105998
5.

D-Dimer versus International Normalized Ratio of Prothrombin Time in Ischemic Stroke Patients Treated with Sufficient Warfarin.

Yamamoto R, Nakae Y, Tanaka F, Johkura K.

J Stroke Cerebrovasc Dis. 2016 Apr 18. pii: S1052-3057(16)00190-7. doi: 10.1016/j.jstrokecerebrovasdis.2016.03.037. [Epub ahead of print]

PMID:
27103270
6.

Cost Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients.

Shah A, Shewale A, Hayes CJ, Martin BC.

Stroke. 2016 Apr 21. pii: STROKEAHA.115.012325. [Epub ahead of print]

PMID:
27103018
7.

A real world data of dabigatran etexilate: multicenter registry of oral anticoagulants in nonvalvular atrial fibrillation.

Yavuz B, Ayturk M, Ozkan S, Ozturk M, Topaloglu C, Aksoy H, Şabanoglu C, Tanalp AC, Dal K, Ata N, Yavuz BB.

J Thromb Thrombolysis. 2016 Apr 16. [Epub ahead of print]

PMID:
27085540
8.

Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: Insights from the J-RHYTHM Registry.

Watanabe E, Yamamoto M, Kodama I, Inoue H, Atarashi H, Okumura K, Yamashita T, Lip GY, Kodani E, Okuyama Y, Chishaki A, Kiyono K, Origasa H; J-RHYTHM Registry Investigators.

Int J Cardiol. 2016 Jun 1;212:311-7. doi: 10.1016/j.ijcard.2016.03.008. Epub 2016 Mar 19.

PMID:
27057949
9.

Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.

Chan EW, Lau WC, Siu CW, Lip GY, Leung WK, Anand S, Man KK, Wong IC.

Heart Rhythm. 2016 Mar 28. pii: S1547-5271(16)30150-3. doi: 10.1016/j.hrthm.2016.03.049. [Epub ahead of print]

PMID:
27033342
10.

Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis.

Joundi RA, Cipriano LE, Sposato LA, Saposnik G; Stroke Outcomes Research Working Group.

Stroke. 2016 May;47(5):1364-7. doi: 10.1161/STROKEAHA.115.012609. Epub 2016 Mar 29.

PMID:
27026630
11.

Use of the SAMe-TT2R2 Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence.

Chan PH, Hai JJ, Chan EW, Li WH, Tse HF, Wong IC, Lip GY, Siu CW.

PLoS One. 2016 Mar 24;11(3):e0150674. doi: 10.1371/journal.pone.0150674. eCollection 2016.

12.

Evaluating the Initiation of Novel Oral Anticoagulants in Medicare Beneficiaries.

Baik SH, Hernandez I, Zhang Y.

J Manag Care Spec Pharm. 2016 Mar;22(3):281-92. doi: 10.18553/jmcp.2016.22.3.281.

13.

[Companion Diagnostics for Thrombotic Disease].

Masuda Y, Matsuno K, Shimizu C.

Rinsho Byori. 2015 Nov;63(11):1316-22. Review. Japanese.

PMID:
26995878
14.

Mortality in Patients With Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 Trial.

Giugliano RP, Ruff CT, Wiviott SD, Nordio F, Murphy SA, Kappelhof JA, Shi M, Mercuri M, Antman EM, Braunwald E.

Am J Med. 2016 Mar 16. pii: S0002-9343(16)30246-7. doi: 10.1016/j.amjmed.2016.02.028. [Epub ahead of print]

15.

Design and Rationale of the RELAXED (Recurrent Embolism Lessened by rivaroxaban, an Anti-Xa agent, of Early Dosing for acute ischemic stroke and transient ischemic attack with atrial fibrillation) Study.

Yasaka M, Minematsu K, Toyoda K, Yamagami H, Yoshimura S, Nagao T, Mori E, Hirano T, Hamasaki T, Yamaguchi T.

J Stroke Cerebrovasc Dis. 2016 Mar 14. pii: S1052-3057(16)00062-8. doi: 10.1016/j.jstrokecerebrovasdis.2016.01.035. [Epub ahead of print]

PMID:
26987488
16.

The Use of Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Patients with History of Intra-Cranial Hemorrhage.

Chao TF, Liu CJ, Liao JN, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chung FP, Chen TJ, Lip GY, Chen SA.

Circulation. 2016 Mar 11. pii: CIRCULATIONAHA.115.019794. [Epub ahead of print]

PMID:
26969761
17.

Factors Associated with Thrombolysis Outcome in Ischemic Stroke Patients with Atrial Fibrillation.

Zhao Q, Li X, Dong W, Ye M, Cao Y, Zhang M, Cheng Q, Zhou J, Chen G, Yu M, Hong S, Wei X, Wang B, Cui G, Zhang P, Ding H, Xu R, Chen Y, Xu Y.

Neurosci Bull. 2016 Apr;32(2):145-52. doi: 10.1007/s12264-016-0019-8. Epub 2016 Mar 7.

PMID:
26951522
18.

Meta-analysis and adjusted indirect comparison of direct oral anticoagulants in prevention of acute limb ischemia in patients with atrial fibrillation.

De Haro J, Bleda S, Varela C, Cañibano C, Acin F.

Curr Med Res Opin. 2016 Apr 7:1-7. [Epub ahead of print]

PMID:
26949899
19.

Temporal Trends in Ischemic Stroke and Anticoagulation Therapy for Nonvalvular Atrial Fibrillation: Impact of Diabetes.

Shroff GR, Solid CA, Bloomgarden Z, Halperin JL, Herzog CA.

J Diabetes. 2016 Feb 29. doi: 10.1111/1753-0407.12392. [Epub ahead of print]

PMID:
26929264
20.

Antikoagulantia efter akut ischemisk stroke med förmaksflimmer - Frågan om rätt tidpunkt för insättning kräver randomiserad klinisk prövning.

Terent A, Åsberg S, Oldgren J, Hijazi Z, Norrving B.

Lakartidningen. 2016 Mar 1;113. pii: DUFT. Swedish.

PMID:
26928683
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk